Palatin Technologies Inc Total Liabilities
Palatin Technologies Inc total liabilities. Based on the latest financial reports, Palatin Technologies Inc (PTN) has total liabilities worth $10.12 Million USD as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Palatin Technologies Inc's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Palatin Technologies Inc (1996–2024)
Total liabilities of Palatin Technologies Inc from 1996 to 2024. This chart illustrates how Palatin Technologies Inc's total liabilities have evolved over time, based on quarterly financial data.
Palatin Technologies Inc Competitors by Total Liabilities
The table below lists competitors of Palatin Technologies Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Munic SA
PA:ALMUN
|
France | €7.13 Million |
|
Interbud-Lublin SA
WAR:ITB
|
Poland | zł52.17 Million |
|
Kumho Industrial Co Ltd
KO:002995
|
Korea | ₩1.14 Trillion |
|
Socket Mobile Inc
NASDAQ:SCKT
|
USA | $9.99 Million |
|
AE Multi Holdings Bhd
KLSE:7146
|
Malaysia | RM62.93 Million |
|
UMT United Mobility Technology AG
XETRA:UMD
|
Germany | €3.32 Million |
|
Henry Boot PLC
LSE:BOOT
|
UK | GBX208.79 Million |
|
Bioatla Inc
NASDAQ:BCAB
|
USA | $45.88 Million |
Liability Composition Analysis (1996–2024)
This chart breaks down Palatin Technologies Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see PTN current and non-current assets.
Liquidity & Leverage Metrics
Palatin Technologies Inc Total Liabilities Ratios Explained
Palatin Technologies Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.58 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2.71 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Palatin Technologies Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Palatin Technologies Inc (1996–2024)
The table below shows the annual total liabilities of Palatin Technologies Inc from 1996 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-06-30 | $10.85 Million | -39.04% |
| 2023-06-30 | $17.81 Million | -10.09% |
| 2022-06-30 | $19.80 Million | +12.23% |
| 2021-06-30 | $17.65 Million | +261.52% |
| 2020-06-30 | $4.88 Million | +16.60% |
| 2019-06-30 | $4.19 Million | -65.27% |
| 2018-06-30 | $12.05 Million | -80.56% |
| 2017-06-30 | $62.00 Million | +116.49% |
| 2016-06-30 | $28.64 Million | +65.82% |
| 2015-06-30 | $17.27 Million | +523.41% |
| 2014-06-30 | $2.77 Million | +32.18% |
| 2013-06-30 | $2.10 Million | -40.96% |
| 2012-06-30 | $3.55 Million | +19.07% |
| 2011-06-30 | $2.98 Million | -2.92% |
| 2010-06-30 | $3.07 Million | -68.94% |
| 2009-06-30 | $9.89 Million | -21.37% |
| 2008-06-30 | $12.57 Million | -48.15% |
| 2007-06-30 | $24.25 Million | +11.50% |
| 2006-06-30 | $21.75 Million | -16.17% |
| 2005-06-30 | $25.94 Million | +419.61% |
| 2004-06-30 | $4.99 Million | +22.83% |
| 2003-06-30 | $4.06 Million | +10.71% |
| 2002-06-30 | $3.67 Million | +57.67% |
| 2001-06-30 | $2.33 Million | +17.59% |
| 2000-06-30 | $1.98 Million | -54.99% |
| 1999-06-30 | $4.40 Million | +41.94% |
| 1998-06-30 | $3.10 Million | -27.91% |
| 1997-06-30 | $4.30 Million | +2.31% |
| 1996-06-30 | $4.20 Million | -- |
About Palatin Technologies Inc
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is… Read more